Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
Comparison of Verapamil With Adenosine After Vagal Maneuvers in Patients Presenting With Paroxysmal Supraventricular Tachycardia (pSVT), in a Tertiary Care Hospital of Lahore, Pakistan
Rashid Latif Medical College
210 participants
Oct 28, 2024
INTERVENTIONAL
Conditions
Summary
Supraventricular tachycardia (SVT) is a term widely used to describe tachycardial dysrhythmias, paroxysmal SVT (PSVT) is a narrow term including only AV nodal re-entrant tachycardia (AVNRT) and atrioventricular re-entrant tachycardia (AVRT), both of which can cause discomfort and, in some cases, life-threatening symptoms. Usually Carotid sinus massage is done to lower the pulse rate and after the standard time specific verapamil dose is administered. In this study after carotid sinus massage Conventional Valsalva or modified Valsalva maneuver will be randomly applied. In case, the normal sinus rhythm (NSR) is not achieved then verapamil of or adenosine dose will be administered to the patients after after taking the consent.
Eligibility
Inclusion Criteria3
- Stable SVT (not requiring cardioversion, fully conscious, maintaining systolic blood pressure of \>90mmHg)
- Alert enough and able to give consent
- Able to lie flat and non-painful legs during passive leg raising
Exclusion Criteria8
- Unstable SVT (Semiconscious, drowsy, breathless, systolic BP \<90mmHg)
- Not able to give consent
- Orthopnea causing inability to lie flat
- Atrial fibrillation/atrial flutter
- Recent MI (within last 7 days)
- Ongoing ischemia as indicated by chest pain or ST segment depression/elevation in ECG
- Aortic stenosis
- All trimesters of pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Adenosine is a medication belonging to class V antidysrhythmics, used to treat a type of irregular heart rhythm disorder known as paroxysmal supraventricular tachycardia (PSVT)
Verapamil is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels so the heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart and slows electrical activity in the heart to control the heart rate.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06717685